Navigation Links
Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call
Date:11/5/2008

CALGARY, Nov. 5 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), will host a conference call and webcast on Thursday, November 6, 2008 at 11:00 a.m. MT (1:00 p.m. ET) to update investors on clinical trial results in its U.S. Phase II trial for patients with bone and soft tissue sarcomas metastatic to the lung. The results are scheduled to be presented November 6, 2008 at the Chemotherapy Foundation Symposium XXVI in New York.

To access the conference call by telephone, dial 1-416-915-5651 or 1-800-732-6179. A live audio webcast will also be available at the following link: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2471700, or through the Company's website at http://www.oncolyticsbiotech.com. Please connect at least 15 minutes prior to the webcast to ensure adequate time for any software download that may be needed. A replay of the webcast will be available at http://www.oncolyticsbiotech.com and will also be available by telephone through November 13, 2008. To access the telephone replay, dial 1-416-640-1917 or 1-877-289-8525 and enter reservation number 21288636 followed by the number sign.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release c
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...CO, Dec. 3 VIA Pharmaceu...pany focused on the development of compounds for t...se, today announced that it has completed the last...al of VIA-2291. ,, The FDG-PET trial enrolled ...he US and Canada including Massachusetts General H...
(Date:12/3/2009)...Calif., Dec. 3 Peregrine...unced that it will release its financial results f...ber 10, 2009 at 7:00 a.m. EST and will host a conf...11:30 a.m. EST on the same day. ,, Peregrine,s ...or the second quarter ended October 31, 2009 and w...
(Date:12/3/2009)... Mass., Dec. 3 Caliper L...vider of tools and services for drug discovery and...mage 4.0 software for IVIS® in vivo imaging s... 800 Caliper IVIS systems currently installed in l...dvanced spectral unmixing tools to enhance fluores...
(Date:12/2/2009)...Md., Dec. 2 Martek Biosc...y that it intends to release the results of its fo...2009, at approximately 4:00 p.m. Eastern Time (ET)...ill conduct a conference call to discuss these res...isten to the call live via webcast by visiting Mar...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2
...n, Wis. Third Wave Technologies Inc. , a Madison ...stic reagents for DNA and RNA analysis application... , ,Napier,s background in general management and ...ve, according to president and CEO Kevin T. Conroy...omen,s markets in the promotion of products at Pr...
...ille, Wis. - Fighting cancer and disposing of exc...first glance. However, a small company in Janesvil...omises to tackle both problems simultaneously. , ,... developer of radiopharmaceuticals, will develop a...ssing small amounts of unused nuclear fuel left ov...
...kee, Wis. - Lifeblood Medical, Inc., a Freehol....25 million in a Series B financing involving 21 p...financing, coordinated through Frederick & Co ., ...feblood Medical to proceed with plans to hire key ... approval for its LIFOR organ preservation solutio...
Other Biology Technology:Napier joins board of Third Wave Technologies 2NorthStar finds cancer-fighting use for nuclear fuel 2Wisconsin investors the lifeblood of New Jersey biotech 2
(Date:12/4/2009)...skovar, a Texas AgriLife Research plant physiologi...nter in Uvalde, has been investigating ways to hel...n from the greenhouse to the field. , "This rese...ibly even the further profitability of some vegeta... plants that will establish well," Leskovar said. ...
(Date:12/4/2009)...lable in German . , A new study of the Max Pl... understand the positive effect of dietary restric...ferent organisms (fruit flies and mice) have shown... with a potential negative side effect of diminish...ess frequently with a reduced litter size on a low...
(Date:12/3/2009)...n new information and adapt to changes in our dail...ies, appears to lie in the minute junctions where ...by NYU Langone Medicine Center researchers. The st...Nature . , The scientists, led by Wen-Biao Gan,...cience at NYU School of Medicine, discovered that ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2NIDDK announces availability of more current kidney disease data 58802 1NIDDK announces availability of more current kidney disease data 58802 2The real world of a forensic scientist 10247 1The real world of a forensic scientist 10247 2Uncertainty Surrounds Testing for Alzheimers 58797 1Uncertainty Surrounds Testing for Alzheimers 58797 2Uncertainty Surrounds Testing for Alzheimers 58797 3
...cargo ships, that can sail throughout the body via...the body,s immune radar system and ferry their car...at might otherwise go untreated or undetected. , ...try journal Angewandte Chemie, scientists at UC ...eir nano-cargo-ship system integrates therapeutic ...
...The International Myeloma Foundation (IMF)supporti...support for myeloma patients, families, researcher...improved dramatically for patients with multiple m...od cell production. Writing in the October 10th ed...chairman Brian G.M. Durie, M.D., notes that 25 yea...
...for Hurricane Ike as it travels over the Gulf of M...Envisat satellite is tracking the storm, which is ... September. , Knowing the strength and path of hu...Earth observation (EO) satellites are key means of...the storm, such as cloud structure, wind and wave ...
Other Biology News:Researchers develop nano-sized 'cargo ships' to target and destroy tumors 2Researchers develop nano-sized 'cargo ships' to target and destroy tumors 3Researchers develop nano-sized 'cargo ships' to target and destroy tumors 4The IMF says journal editorial documents dramatic increase in survival since the 1980s 2Hurricane Ike tracked by ESA's Envisat 2
...ed Console Orbital Shakers combine high durability...equalled programming power. The patented triple-c...tion, allowing the unit to run with heavy out-of-b...educes contamination. The heavy stainless steel i...
Immulon 1 B 1x12 Strip from Thermo Scientific
Horizontal Plus 0.9 (230V / 50Hz) from Thermo Scientific
RapidStak from Thermo Scientific
Biology Products: